Why Is ELANCO ANIMAL HEALTH (ELAN) Stock Down Today?
By the Top Tier Newswire AI Desk · August 10, 2026 at 12:17 AM ET · reviewed against 3 wire stories
ELANCO ANIMAL HEALTH (ELAN) is down -8.60% in the latest session. Our newswire has captured 3 stories on ELAN across 3 sources in the last 36 hours, with AI sentiment reading bullish (avg 65/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Elanco Animal Health’s stock closed down 8.60% at $22.12 on Wednesday, marking a sharp reversal from recent gains. The decline followed a mixed set of developments, including a strong earnings call and product authorization, but appears to reflect broader market pressure or investor reassessment of the stock’s valuation and momentum.
What Happened
Elanco reported second-quarter 2026 revenue of $1.368 billion, up 10% on a reported basis and 8% organically, driven by strong demand for new pet-health products and performance in U.S. farm markets. The company also announced that its CLiK™ Extra wound spray received FDA Emergency Use Authorization for preventing New World Screwworm infestations in livestock and wildlife. Technical experts emphasized the importance of vigilance and early intervention in mitigating the parasite’s spread. Despite these developments, the stock fell sharply, with no direct explanation from the company or analysts in the most recent coverage. UBS and Keybanc both raised price targets for ELAN in recent days, maintaining Buy and Overweight ratings respectively.
What The Data Shows
Elanco’s fundamentals remain mixed. The company has a market cap of $12.1 billion and is currently unprofitable, with a trailing twelve-month EPS of -0.41 and a net margin of -4.0%. Revenue has grown by 12.0% in the past twelve months, but the stock’s beta of 1.69 suggests it is more volatile than the broader market. Insiders, including CEO Jeffrey N. Simmons, purchased shares on May 15, and recent insider filings show two buys totaling $200,000 in the last 90 days. The stock is currently trading within its 52-week range of $15.50 to $27.98.
What To Watch
The stock’s sharp decline may reflect broader market sentiment or a reassessment of its valuation. Investors should continue to monitor coverage breadth and any follow-up commentary from analysts or the company.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
ELAN · today's session (5-min) · +1.97% vs prior close · updated 3:16 PM ETAI sentiment, last 36h · averaged over 3 stories · 65/100 bullish
The headlines behind the move
Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
20h agoTipRanksBULLISH 67Earnings
Elanco Animal Health Ups Guidance on Innovation Strength
Elanco Animal Health (($ELAN)) has held its Q2 earnings call. Read on for the main highlights of the call. Elanco Animal Health’s latest earnings call struck a nota...
2d agoYahoo TopBULLISH 65Earnings
Elanco Animal Health Q2 Earnings Call Highlights
Elanco Animal Health (NYSE:ELAN) reported second-quarter 2026 revenue of $1.368 billion, up 10% on a reported basis and 8% organically in constant currency, as demand for new pet-health products and strength in U.S. farm animal operations supported growth. Chief Executive Officer Jeff Simmons said
3d agoStockTitanBULLISH 63Product/PR
Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species
Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical experts Emergency Use Authorization for Elanco's CLiK Extra provides livestock producers with a vital tool in the prevention of New World screwworm...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →